Wayne S DeVeydt
CIK 1321392 · Chief Financial Officer · last filed 2026-09-24
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
WLP price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
EDEN PRAIRIE, MN 55344
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| UNH | Chief Financial Officer | 18,675 | $410.70 | $7.67M | $0 | 8 | 2026-09-24 |
| CENTENE CORP (CNTE) Delisted | Director | 19,523 | — | — | $0 | 19 | 2025-07-02 |
| SGRY | Exec Chairman of the Board | 105,203 | $23.25 | $2.45M | -$9.79M | 19 | 2025-03-25 |
| NI | Director | 35,480 | $43.44 | $1.54M | $0 | 7 | 2021-05-26 |
| Myovant Sciences Ltd. (MYOV) Delisted | Director | — | $26.98 | — | $0 | 2 | 2017-10-20 |
| ANTX | EVP & Chief Financial Officer | 57,957 | $3.63 | $210.4K | -$1.00M | 3 | 2016-03-04 |
| Elevance Health, Inc. (ANTM) Delisted | EVP & Chief Financial Officer | 82,126 | $482.58 | $39.63M | -$18.37M | 3 | 2015-04-08 |
| Elevance Health, Inc. (WLP) Delisted | EVP & Chief Financial Officer | 128,442 | — | — | -$49.80M | 27 | 2014-11-12 |
Recent Filings · Page 6 of 12
118 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-10-03 | CENTENE CORP (CNTE) Delisted | Grant (A) | +582 | $0 | EDGAR |
| 2023-07-05 | CENTENE CORP (CNTE) Delisted | Grant (A) | +581 | $0 | EDGAR |
| 2023-05-16 | SGRY | Gift (G) | −18,999 | $0 | EDGAR |
| 2023-05-12 | CENTENE CORP (CNTE) Delisted | Grant (A) | +2,947 | $0 | EDGAR |
| 2023-04-04 | CENTENE CORP (CNTE) Delisted | Grant (A) | +440 | $0 | EDGAR |
| 2023-03-28 | SGRY | Grant (A) | +20,408 | $0 | EDGAR |
| 2023-01-04 | CENTENE CORP (CNTE) Delisted | Grant (A) | +382 | $0 | EDGAR |
| 2022-10-04 | CENTENE CORP (CNTE) Delisted | Grant (A) | +349 | $0 | EDGAR |
| 2022-07-05 | CENTENE CORP (CNTE) Delisted | Grant (A) | +376 | $0 | EDGAR |
| 2022-05-05 | SGRY | Sell (S) | −60,000 | -$3.34M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.